REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $544 | -99.9% | 14,327 | -57.4% | 0.01% | -27.3% |
| Q3 2022 | $844,000 | -77.2% | 33,594 | -72.4% | 0.01% | -75.6% |
| Q2 2022 | $3,700,000 | +661.3% | 121,750 | +721.4% | 0.04% | +650.0% |
| Q1 2022 | $486,000 | -71.9% | 14,823 | -77.4% | 0.01% | -66.7% |
| Q4 2021 | $1,729,000 | -21.6% | 65,558 | +196.3% | 0.02% | -43.8% |
| Q1 2021 | $2,206,000 | +216.0% | 22,123 | +292.0% | 0.03% | +357.1% |
| Q4 2020 | $698,000 | -70.8% | 5,644 | -63.1% | 0.01% | -88.7% |
| Q2 2020 | $2,387,000 | +277.7% | 15,298 | +249.3% | 0.06% | +77.1% |
| Q1 2020 | $632,000 | -59.6% | 4,379 | -42.7% | 0.04% | +20.7% |
| Q4 2019 | $1,563,000 | +548.5% | 7,647 | +154.9% | 0.03% | +262.5% |
| Q3 2019 | $241,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |